Straight Outta Wisconsin, LynxBio Wins EvoNexus Best Demo Vote
Summary
LynxBio won the best demo vote at EvoNexus Spring Demo Day after pitching its microfluidic technology for testing cancer treatment responses. The company uses live cancer cells to simulate how multiple myeloma patients may respond to different drug combinations. LynxBio has already funded development with $4.3 million in non-dilutive research grants and is now raising $1.25 million in seed capital. The startup has also joined the EvoNexus incubator and JLABS innovation program in San Diego.
Funding
Amount
$1.3M
Total raised
Date
April 2, 2018
Announcement date
Investors
EvoNexus
Lead investors
Company
lynxbio.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected